Clinical Trials for Hereditary Hemorrhagic Telangiectasia

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

NCT ID: NCT06259292

The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is a study aimed at understanding Hereditary Hemorrhagic Telangiectasia (HHT), a condition that causes abnormal blood vessel fo...

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT ID: NCT05641142

This clinical trial is looking to understand how well patients with Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler Disease, tolerate treatment with blood-thinning medication...

Quality of Life in Patients With Hemorrhagic Telangiectasia

NCT ID: NCT06261333

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

NCT ID: NCT04469517

This clinical trial is studying how certain factors related to low oxygen levels (called hypoxic induced factors) might affect patients with hereditary hemorrhagic telangiectasia (HHT). HHT is a ge...

Bevacizumab In Hereditary Hemorrhagic Telangiectasia

NCT ID: NCT04404881

This clinical trial is investigating whether a medication called bevacizumab can help treat chronic bleeding and iron deficiency anemia in people with Hereditary Hemorrhagic Telangiectasia (HHT). H...

Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT ID: NCT03850730

This clinical trial is studying a medication called Pazopanib to see if it can help reduce frequent and severe nosebleeds (epistaxis) in people with a genetic condition known as hereditary hemorrha...